Phathom Pharmaceuticals (PHAT) EPS (2018 - 2026)
Phathom Pharmaceuticals (PHAT) EPS from Dec 31, 2018 to Mar 31, 2026. The TTM Phathom Pharmaceuticals (PHAT) EPS is -$2.18. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual EPS
Quarterly EPS
Phathom Pharmaceuticals (PHAT) EPS CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | -47.65% |
| 3 Years TTM | -14.05% |
| 5 Years TTM | -16.04% |
| All Time TTM | -19.09% |
Annual EPS change of Phathom Pharmaceuticals (PHAT)
| Year | EPS | Change |
|---|---|---|
| 2026 | -$0.38 | -87.66% |
| 2025 | -$3.10 | -36.51% |
| 2024 | -$4.88 | +40.31% |
| 2023 | -$3.48 | -27.06% |
| 2022 | -$4.77 | +29.60% |
| 2021 | -$3.68 | -18.72% |
| 2020 | -$4.53 | -44.78% |
| 2019 | -$8.20 | +24928.52% |
| 2018 | -$0.03 | N/A |
Comparison Phathom Pharmaceuticals (PHAT) five years EPS CAGR with competitors
Phathom Pharmaceuticals (PHAT) five years EPS CAGR is -24.73%.